News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
864,920 Results
Type
Article (87869)
Company Profile (748)
Press Release (776284)
Multimedia
Podcasts (198)
Webinars (28)
Section
Business (233107)
Career Advice (4144)
Deals (39881)
Drug Delivery (150)
Drug Development (91322)
Employer Resources (205)
FDA (18346)
Job Trends (17428)
News (397574)
Policy (39961)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3005)
Academic (1)
Accelerated approval (33)
Adcomms (36)
Allergies (143)
Alliances (56940)
ALS (176)
Alzheimer's disease (1773)
Antibody-drug conjugate (ADC) (333)
Approvals (18503)
Artificial intelligence (533)
Autoimmune disease (156)
Automation (34)
Bankruptcy (405)
Best Places to Work (12581)
BIOSECURE Act (23)
Biosimilars (204)
Biotechnology (458)
Bladder cancer (148)
Brain cancer (56)
Breast cancer (599)
Cancer (4692)
Cardiovascular disease (373)
Career advice (3570)
Career pathing (41)
CAR-T (300)
CDC (51)
Celiac Disease (2)
Cell therapy (791)
Cervical cancer (33)
Clinical research (76665)
Collaboration (1766)
Company closure (5)
Compensation (1120)
Complete response letters (69)
COVID-19 (2960)
CRISPR (93)
C-suite (820)
Cystic fibrosis (147)
Data (5878)
Decentralized trials (2)
Denatured (73)
Depression (138)
Diabetes (420)
Diagnostics (7113)
Digital health (38)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (272)
Drug pricing (225)
Drug shortages (35)
Duchenne muscular dystrophy (223)
Earnings (99358)
Editorial (64)
Employer branding (25)
Employer resources (173)
Events (133872)
Executive appointments (960)
FDA (21145)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (9)
Frontotemporal dementia (24)
Funding (1403)
Gene editing (198)
Generative AI (50)
Gene therapy (617)
GLP-1 (1086)
Government (5437)
Grass and pollen (8)
Guidances (349)
Healthcare (20861)
HIV (55)
Huntington's disease (50)
IgA nephropathy (84)
Immunology and inflammation (286)
Immuno-oncology (60)
Indications (96)
Infectious disease (3218)
Inflammatory bowel disease (203)
Inflation Reduction Act (17)
Influenza (108)
Intellectual property (229)
Interviews (816)
IPO (17902)
IRA (60)
Job creations (5200)
Job search strategy (2866)
JPM (70)
Kidney cancer (16)
Labor market (93)
Layoffs (656)
Leadership (39)
Legal (10149)
Liver cancer (91)
Longevity (14)
Lung cancer (631)
Lymphoma (363)
Machine learning (42)
Management (66)
Manufacturing (820)
MASH (167)
Medical device (14599)
Medtech (14638)
Mergers & acquisitions (22937)
Metabolic disorders (1262)
Multiple sclerosis (157)
NASH (23)
Neurodegenerative disease (344)
Neuropsychiatric disorders (97)
Neuroscience (3046)
Neurotech (1)
NextGen: Class of 2026 (7687)
Non-profit (5094)
Now hiring (66)
Obesity (646)
Opinion (330)
Ovarian cancer (160)
Pain (198)
Pancreatic cancer (196)
Parkinson's disease (290)
Partnered (37)
Patents (466)
Patient recruitment (447)
Peanut (58)
People (66680)
Pharmaceutical (139)
Pharmacy benefit managers (33)
Phase 1 (23723)
Phase 2 (33321)
Phase 3 (25056)
Pipeline (4927)
Policy (334)
Postmarket research (3550)
Preclinical (10630)
Press Release (72)
Prostate cancer (236)
Psychedelics (52)
Radiopharmaceuticals (295)
Rare diseases (885)
Real estate (7436)
Recruiting (80)
Regulatory (28706)
Reports (66)
Research institute (2713)
Resumes & cover letters (651)
Rett syndrome (21)
RNA editing (21)
RSV (75)
Schizophrenia (155)
Series A (241)
Series B (179)
Service/supplier (28)
Sickle cell disease (100)
Special edition (27)
Spinal muscular atrophy (175)
Sponsored (47)
Startups (4327)
State (2)
Stomach cancer (16)
Supply chain (108)
Tariffs (100)
The Weekly (123)
Vaccines (1071)
Venture capital (94)
Weight loss (449)
Women's health (85)
Worklife (22)
Date
Last 7 days (569)
Last 30 days (1897)
Last 365 days (29104)
2026 (2749)
2025 (29541)
2024 (36312)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1280)
Alabama (91)
Alaska (7)
Arizona (309)
Arkansas (11)
Asia (51406)
Australia (9029)
California (10639)
Canada (3139)
China (1134)
Colorado (439)
Connecticut (455)
Delaware (315)
Europe (117843)
Florida (1512)
Georgia (315)
Hawaii (4)
Idaho (67)
Illinois (882)
India (65)
Indiana (512)
Iowa (23)
Japan (404)
Kansas (133)
Kentucky (40)
Louisiana (24)
Maine (63)
Maryland (1368)
Massachusetts (7880)
Michigan (325)
Minnesota (532)
Mississippi (6)
Missouri (103)
Montana (32)
Nebraska (29)
Nevada (120)
New Hampshire (65)
New Jersey (2955)
New Mexico (33)
New York (2789)
North Carolina (1560)
North Dakota (10)
Northern California (5090)
Ohio (317)
Oklahoma (20)
Oregon (51)
Pennsylvania (2182)
Puerto Rico (23)
Rhode Island (45)
South America (1664)
South Carolina (23)
South Dakota (1)
Southern California (4173)
Tennessee (128)
Texas (1572)
United States (38152)
Utah (251)
Vermont (1)
Virginia (263)
Washington D.C. (82)
Washington State (912)
West Virginia (4)
Wisconsin (104)
Wyoming (1)
864,920 Results for "ajinomoto bio pharma services".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Ajinomoto Bio-Pharma Services Garners Six ‘CDMO Leadership Awards,’ Further Establishing Its Industry Excellence
Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical contract development and manufacturing services, received CDMO Leadership Awards in all six categories - Capabilities, Compatibility, Expertise, Quality, Reliability, and Service for both the Overall and Big Pharma respondent groups.
March 12, 2024
·
2 min read
Press Releases
AlzeCure Pharma Selected to Present at the Bio-Neuroscience conference in Amsterdam
February 2, 2026
·
3 min read
Press Releases
Pharma-Bio Serv Announces Full Year Results and Special Dividend - January 29, 2026
January 30, 2026
·
3 min read
Mergers & acquisitions
At JPM26, Policy and Politics Will Loom Large for Pharma as Biotech Sees the Sun
Pharmas will need to provide their latest stance on the Most Favored Nation drug pricing plans, while biotech finally gets a break after a few tough years.
January 9, 2026
·
4 min read
·
Annalee Armstrong
Press Releases
PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea
April 24, 2025
·
3 min read
Insights
Five Trends That Got Everyone Talking in Pharma and Biotech This Year
In 2025, landmark obesity drug deals, China’s biotech surge, and AI’s deeper integration into pharma operations drove a year of transformation and renewed momentum for life sciences.
November 12, 2025
·
5 min read
·
Jennifer Smith-Parker
Business
Ajinomoto Bio-Pharma Services Announces Leadership Changes at US Facility
Ajinomoto Bio-Pharma Services today announced leadership changes at the company’s site in San Diego, effective immediately.
May 18, 2023
·
3 min read
Press Releases
Bio-Sourcing and Zerion Pharma join forces to develop first HER2 oral monoclonal antibody against breast cancer
January 12, 2026
·
1 min read
Press Releases
Bio-Sourcing and Zerion Pharma Join Forces to Develop First HER2 Oral Monoclonal Antibody Against Breast Cancer
January 12, 2026
·
4 min read
Drug pricing
Despite MFN Deals, Drug Pricing Will Dog Pharma Into 2026
Only a handful of the top pharmas have signed Most Favored Nation drug pricing deals with the White House, while smaller biotechs continue to hang in limbo.
January 6, 2026
·
5 min read
·
Annalee Armstrong
1 of 86,492
Next
